Bristol Myers (BMY) Stock: Here’s What You Need To Know

Bristol Myers (NYSE:BMY) On August 5, 2016 Bristol Myers had a very rough day with respect to one of its targets in the pipeline.  The company’s PD-1 immune checkpoint inhibitor, known as Opdivo, failed to meet the primary endpoint of a phase 3 clinical trial. Bristol Myer’s stock did not have a good day after … Read more

Biotech Stock News (BLUE) (SNTA) (MACK) (BXLT)

Bluebird Bio (NASDAQ:BLUE)  On October 19, 2015 shares of Bluebird Bio fell approximately 4% after the company announced that one patient on its old generation gene therapy had required two blood transfusions due to anemia. One thing to keep in mind was that this patient was blood transfusion free for 7 years and that’s why … Read more

Biotech Stock News (NVS) (AVEO) (OMER) (VTL)

Aveo Oncology (NASDAQ:AVEO) & Novartis (NYSE:NVS) On August 17, 2015 shares of Aveo reached as high as 126% in one day after the company announced a partnership with Novartis. Under the terms of the agreement Novartis will make an upfront payment to Aveo for $15 million. This is in exchange for a partnership for both … Read more

Biotech Stock News (INO) (AZN) (IMUC) (AAVL) (REGN)

Inovio Pharmaceuticals (NASDAQ:INO) On August 10, 2015 shares of Inovio were up about 25% after the company announced a partnership deal with a big pharmaceutical company known as AstraZeneca (NYSE:AZN). Although one key thing to note here is that this deal is being established with MedImmune specifically, but it is the research and development arm for … Read more

Biotech Stock News (SRPT) (BMRN) (PBMD) (ISR)

Sarepta Therapeutics (NASDAQ:SRPT) After the closing bell on May 19, 2015 shares of Sarepta Therapeutics were up as much as 38% in after-hours trading after the company reported that the FDA will allow the company to file a New Drug Application — NDA — for Eteplirsen. This drug Eteplirsen helps patients with Duchenne Muscular Dystrophy … Read more